AEON Biopharma, Inc. (AEON) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $0.25 (0.00%)
Consensus Target
—
Upside
—
Analysts
1
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
AEON vs Sector & Market
| Metric | AEON | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | — | +22217.1% | +21.5% |
| P/E Ratio | -0.30 | 3.76 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16M | $16M | $16M | 1 |
| 2027-12-31 | $2M | $2M | $2M | 1 |
| 2028-12-31 | $88M | $88M | $88M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-50.40 | $-50.40 | $-50.40 | 1 |
| 2027-12-31 | $-30.24 | $-30.24 | $-30.24 | 1 |
| 2028-12-31 | $16.56 | $16.56 | $16.56 | 1 |
Frequently Asked Questions
What is the analyst consensus for AEON?
The consensus among 1 analysts covering AEON Biopharma, Inc. (AEON) is Buy with an average price target of N/A.
How many analysts cover AEON?
1 analysts have issued ratings for AEON Biopharma, Inc. in the past 12 months.
Is AEON a buy or sell right now?
Based on 1 analyst ratings, AEON has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for AEON?
Analysts estimate AEON will report EPS of $-50.40 for the period ending 2026-12-31, with revenue estimated at $16M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.